Comprehensive Evaluation of the Revised International Staging System in Multiple Myeloma Patients Treated With Novel Agents as a Primary Therapy

American Journal of Hematology - United States
doi 10.1002/ajh.24891
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Value of Novel Agents and Intensive Therapy for Patients With Multiple Myeloma

Bone Marrow Transplantation
TransplantationHematology
2013English

Chromosome 1 Abnormalities in Elderly Patients With Newly Diagnosed Multiple Myeloma Treated With Novel Therapies

Haematologica
Hematology
2014English

Survival Outcomes of Patients With Primary Plasma Cell Leukemia (pPCL) Treated With Novel Agents

Cancer
Cancer ResearchOncology
2018English

Clinical and Economic Study of Daratumumab in Combination Therapy for Previously Treated Patients With Multiple Myeloma

Medical Technologies. Assessment and Choice (Медицинские технологии. Оценка и выбор)
2019English

Revised-International Staging System (R-Iss) Is Predictive and Prognostic for Early Relapse (<24 Months) After Autologous Transplantation for Newly Diagnosed Multiple Myeloma (MM)

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Multiple Myeloma: Future Directions in Autologous Transplantation and Novel Agents

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

Kinase Inhibitors as Potential Agents in the Treatment of Multiple Myeloma

Oncotarget
Oncology
2016English

Prognostic Significance of Upfront Radiation Therapy in Patients With Multiple Myeloma

American Journal of Hematology
Hematology
2019English

Multiple Myeloma With Primary Amyloidosis

Journal of the Royal Society of Medicine
Medicine
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy